Ra Capital Management as of March 31, 2014
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 31 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sangamo Biosciences (SGMO) | 14.6 | $203M | 11M | 18.08 | |
| Gilead Sciences (GILD) | 12.2 | $170M | 2.4M | 70.86 | |
| ACADIA Pharmaceuticals (ACAD) | 9.6 | $134M | 5.5M | 24.33 | |
| Achillion Pharmaceuticals | 6.2 | $87M | 26M | 3.29 | |
| Dyax | 5.1 | $71M | 7.9M | 8.98 | |
| Dicerna Pharmaceuticals | 4.9 | $69M | 2.4M | 28.25 | |
| Therapeuticsmd | 4.5 | $62M | 9.8M | 6.31 | |
| Ophthotech | 4.5 | $62M | 1.7M | 35.67 | |
| Enanta Pharmaceuticals (ENTA) | 4.4 | $62M | 1.5M | 39.99 | |
| Prothena (PRTA) | 4.3 | $60M | 1.6M | 38.31 | |
| Arrowhead Research | 3.5 | $48M | 2.9M | 16.42 | |
| BioCryst Pharmaceuticals (BCRX) | 3.3 | $46M | 4.3M | 10.58 | |
| Novavax | 3.2 | $45M | 9.9M | 4.53 | |
| Dynavax Technologies Corporation | 2.3 | $32M | 18M | 1.81 | |
| Sunesis Pharmaceuticals | 2.3 | $32M | 4.9M | 6.61 | |
| Xencor (XNCR) | 2.3 | $32M | 2.7M | 11.73 | |
| Ptc Therapeutics I (PTCT) | 1.8 | $26M | 982k | 26.14 | |
| Repros Therapeutics | 1.8 | $26M | 1.4M | 17.74 | |
| Tesaro | 1.5 | $21M | 700k | 29.48 | |
| Neurocrine Biosciences (NBIX) | 1.4 | $19M | 1.2M | 16.10 | |
| Derma Sciences | 1.2 | $17M | 1.3M | 12.68 | |
| Mirati Therapeutics | 0.9 | $13M | 657k | 19.07 | |
| Bluebird Bio (BLUE) | 0.8 | $11M | 467k | 22.74 | |
| pSivida | 0.8 | $11M | 2.6M | 4.10 | |
| InterMune | 0.7 | $10M | 301k | 33.47 | |
| Flexion Therapeutics | 0.5 | $7.4M | 450k | 16.45 | |
| Ocera Therapeutics | 0.4 | $5.6M | 528k | 10.55 | |
| Macrogenics (MGNX) | 0.4 | $5.5M | 199k | 27.83 | |
| Alimera Sciences | 0.4 | $5.3M | 667k | 7.89 | |
| Mei Pharma | 0.3 | $4.5M | 408k | 11.13 | |
| Prana Biotechnology | 0.0 | $280k | 100k | 2.80 |
